Literature DB >> 2321125

Clinical evaluation of the response to surgical treatment of Graves' disease.

Y Kasuga1, A Sugenoya, S Kobayashi, G Kaneko, H Masuda, M Fujimori, F Iida.   

Abstract

Included in this study are 513 patients with Graves' disease who underwent thyroidectomy between 1970 and 1983. The patients were divided into three groups by dividing the period in which the surgical procedures were done. The weight of the remnant of the thyroid gland and the incidence of surgical complications were collated for the patients in each group studied. Postoperative function of the thyroid gland was evaluated clinically and biochemically and compared with the remnant weight and total weight of the thyroid gland. The remnant weight was greatest in the first period and least in the third period. There were no differences between the frequencies of postoperative complications among the three groups in site of a remarkable decrease of the remnant weight in the third period. Remission of hyperthyroidism, including those with a latent hypothyroid state, was most frequently observed in the group in which the remnant weight was from 4 to less than 8 grams. These results indicate that the remnant weight appears to be one of the most crucial factors influencing the postoperative outcome; it thus seems appropriate to leave only small remnants of the thyroid gland (4 to less than 8 grams) at thyroidectomy. In our hands, surgical treatment is an effective and safe procedure for Graves' disease, although the precise mechanism for the remission induced by this procedure has not been elucidated.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2321125

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  6 in total

1.  Follow-up evaluation of patients with Graves' disease treated by subtotal thyroidectomy and risk factor analysis for post-operative thyroid dysfunction.

Authors:  K Sugino; T Mimura; K Toshima; H Iwabuchi; Y Kitamura; M Kawano; O Ozaki; K Ito
Journal:  J Endocrinol Invest       Date:  1993-03       Impact factor: 4.256

2.  The outcome of patients with thyroid carcinoma and Graves' disease.

Authors:  Y Kasuga; A Sugenoya; S Kobayashi; H Masuda; F Iida
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

3.  Early recurrence of hyperthyroidism in patients with Graves' disease treated by subtotal thyroidectomy.

Authors:  K Sugino; T Mimura; O Ozaki; Y Kure; H Iwasaki; N Wada; A Matsumoto; K Ito
Journal:  World J Surg       Date:  1995 Jul-Aug       Impact factor: 3.352

4.  Retrospective analysis of prognostic factors affecting the thyroid functional status after subtotal thyroidectomy for Graves' disease.

Authors:  T Okamoto; Y Fujimoto; T Obara; Y Ito; M Aiba
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

5.  Could total thyroidectomy become the standard treatment for Graves' disease?

Authors:  Ayhan Koyuncu; Cengiz Aydin; Omer Topçu; Oruç Numan Gökçe; Sahande Elagöz; Hatice Sebila Dökmetaş
Journal:  Surg Today       Date:  2009-12-29       Impact factor: 2.549

6.  Papillary thyroid carcinoma and inflammation.

Authors:  Laura Fugazzola; Carla Colombo; Michela Perrino; Marina Muzza
Journal:  Front Endocrinol (Lausanne)       Date:  2011-12-16       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.